logo
Intelligence
Tracking
Tools
logo
Intelligence
Tracking
Tools

Akari Therapeutics Plc Appoints Abizer Gaslightwala As President and CEO

Mar 20, 2025•9 months ago

Position

Chief Executive Officer

Company

Akari Therapeutics

Abizer Gaslightwala
TamparesearchBiotechnology

Description

Akari Therapeutics Plc announced the appointment of Abizer Gaslightwala as President and Chief Executive Officer (CEO), effective April 21, 2025. He brings 25 years of experience in the biotechnology and pharmaceutical industry, having most recently served as the Senior Vice President and Franchise Head for US Oncology at Jazz Pharmaceuticals.

Company Information

Company

Akari Therapeutics

Location

401 EAST JACKSON STREET

Tampa, Florida, United States

About

Akari Therapeutics is an oncology biotech company developing novel antibody drug conjugates (ADCs) with its first payload, PH1, a spliceosome modulator that disrupts RNA splicing in cancer cells. Unlike traditional ADC payloads, PH1 induces cancer cell death while activating immune responses, showing robust and durable activity in preclinical models.

Related People

Sign in to view contact details

Sign in to view contact details

Sign in to view contact details

Executive Insights

Based on hiring data
New executive impact window
87% of new executives make significant technology decisions within first 100 days
Budget influence
C-level executives control 73% of technology spending decisions
Transformation catalyst
65% of new senior hires launch digital transformation initiatives
Vendor review timeline
New executives typically review existing vendors within 6 months